Nothing Special   »   [go: up one dir, main page]

CY1319A - Oximes derived from erythromycin a,their preparation,their application in pharmaceuticals and pharmaceutical compositions containing them - Google Patents

Oximes derived from erythromycin a,their preparation,their application in pharmaceuticals and pharmaceutical compositions containing them

Info

Publication number
CY1319A
CY1319A CY1319A CY131981A CY1319A CY 1319 A CY1319 A CY 1319A CY 1319 A CY1319 A CY 1319A CY 131981 A CY131981 A CY 131981A CY 1319 A CY1319 A CY 1319A
Authority
CY
Cyprus
Prior art keywords
erythromycin
pharmaceuticals
preparation
application
pharmaceutical compositions
Prior art date
Application number
CY1319A
Other languages
English (en)
Inventor
D Ambrieres Solange Gouin
Andre Lutz
Jean-Claude Gasc
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9237443&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY1319(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Publication of CY1319A publication Critical patent/CY1319A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
CY1319A 1980-01-11 1981-01-09 Oximes derived from erythromycin a,their preparation,their application in pharmaceuticals and pharmaceutical compositions containing them CY1319A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8000566A FR2473525A1 (fr) 1980-01-11 1980-01-11 Nouvelles oximes derivees de l'erythromycine, leur procede de preparation et leur application comme medicaments

Publications (1)

Publication Number Publication Date
CY1319A true CY1319A (en) 1986-03-28

Family

ID=9237443

Family Applications (1)

Application Number Title Priority Date Filing Date
CY1319A CY1319A (en) 1980-01-11 1981-01-09 Oximes derived from erythromycin a,their preparation,their application in pharmaceuticals and pharmaceutical compositions containing them

Country Status (25)

Country Link
US (1) US4349545A (zh)
EP (1) EP0033255B1 (zh)
JP (1) JPS56100799A (zh)
KR (1) KR850000964B1 (zh)
AU (1) AU537247B2 (zh)
BG (1) BG61369B2 (zh)
CA (1) CA1162535A (zh)
CY (1) CY1319A (zh)
DE (1) DE3165720D1 (zh)
DK (1) DK157878C (zh)
ES (1) ES8200702A1 (zh)
FI (1) FI69473C (zh)
FR (1) FR2473525A1 (zh)
GR (1) GR73103B (zh)
GT (1) GT198500080A (zh)
HK (1) HK586A (zh)
HU (1) HU187760B (zh)
IE (1) IE50680B1 (zh)
IL (1) IL61808A (zh)
LU (1) LU88283I2 (zh)
MY (1) MY8500984A (zh)
NL (1) NL930097I2 (zh)
OA (1) OA06719A (zh)
PT (1) PT72331B (zh)
ZA (1) ZA808108B (zh)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2534588B2 (fr) * 1982-10-15 1985-09-20 Roussel Uclaf Nouvelles oximes derivees de l'erythromycine, leur procede de preparation et leur application comme medicaments
US4526889A (en) * 1982-11-15 1985-07-02 Pfizer Inc. Epimeric azahomoerythromycin A derivative, intermediates and method of use
DK149776C (da) * 1984-01-06 1987-04-21 Orion Yhtymae Oy Antibiotisk virksom erytromycinforbindelse og praeparat indeholdende forbindelsen
JPS60214796A (ja) * 1984-04-06 1985-10-28 Taisho Pharmaceut Co Ltd 6−0−メチルエリスロマイシン類の製法
JPS61103890A (ja) * 1984-10-26 1986-05-22 Taisho Pharmaceut Co Ltd 6−0−メチルエリスロマイシンa誘導体
NO860901L (no) 1985-03-12 1986-09-15 Beecham Group Plc Fremgangsmaate for fremstilling av farmasoeytisk aktive erytromycinderivater.
JPS61229895A (ja) * 1985-04-03 1986-10-14 Nippon Zeon Co Ltd 保護化デス−n−メチルエリスロマイシン誘導体
US4740502A (en) * 1986-06-20 1988-04-26 Abbott Laboratories Semisynthetic erythromycin antibiotics
DE3782994T2 (de) 1986-09-18 1993-04-08 Taisho Pharma Co Ltd Erythromycin-a-derivate und verfahren zu ihrer herstellung.
JP2751385B2 (ja) * 1988-05-19 1998-05-18 大正製薬株式会社 エリスロマイシンaオキシム及びその塩の製造方法
US5075289A (en) * 1988-06-07 1991-12-24 Abbott Laboratories 9-r-azacyclic erythromycin antibiotics
US5302705A (en) * 1989-10-07 1994-04-12 Taisho Pharmaceutical Co., Ltd. 6-O-methylerythromycin a oxime derivatives
EP0503932B1 (en) 1991-03-15 1998-12-02 Merck & Co. Inc. 9-Deoxo-9(z)-hydroxy-iminoerythromycin A and O-derivatives thereof
US5912331A (en) * 1991-03-15 1999-06-15 Merck & Co., Inc. Process for the preparation of 9-deoxo-9(Z)-hydroxyiminoerythromycin A
US5985844A (en) * 1992-03-26 1999-11-16 Merck & Co., Inc. Homoerythromycin A derivatives modified at the 4"-and 8A-positions
US5189159A (en) * 1992-04-02 1993-02-23 Merck & Co., Inc. 8a-AZA-8a-homoerythromycin cyclic iminoethers
ES2036472B1 (es) * 1991-10-01 1994-03-01 Prodesfarma Sa Procedimiento de obtencion de eritromicina 9-(0-((2-metoxietoxi)metil)oxima) (roxitromicina).
US5210235A (en) * 1992-08-26 1993-05-11 Merck & Co., Inc. Methods of elaborating erythromycin fragments into amine-containing fragments of azalide antibiotics
US5332807A (en) * 1993-04-14 1994-07-26 Merck & Co., Inc. Process of producing 8A- and 9A-azalide antibiotics
KR970702725A (ko) * 1994-04-26 1997-06-10 노부히로 나리따 비소세포 폐암 치료용 의약 조성물(Medicinal Composition as a Remedy for Nonsmall Cell Lung Cancer)
IT1276901B1 (it) * 1994-12-13 1997-11-03 Zambon Spa Derivati dell'eritromicina a 9-0-ossina dotati di attivita' antibiotica
US5872229A (en) 1995-11-21 1999-02-16 Abbott Laboratories Process for 6-O-alkylation of erythromycin derivatives
FR2760017B1 (fr) * 1997-02-27 1999-04-30 Hoechst Marion Roussel Inc Nouveaux derives de l'erytromycine, leur procede de preparation et leur application comme medicaments
US5929219A (en) 1997-09-10 1999-07-27 Abbott Laboratories 9-hydrazone and 9-azine erythromycin derivatives and a process of making the same
PT102202B (pt) * 1998-09-10 2001-04-30 Hovione Sociedade Quimica S A Processo para a purificacao de roxitromicina
IN190782B (zh) * 1998-09-30 2003-08-23 Max India Ltd
DE69813244T2 (de) * 1998-11-24 2004-03-04 Jubilant Organosys Ltd. Verfahren zur Herstellung von Roxithromycin und Derivate davon
IL150227A0 (en) * 1999-12-16 2002-12-01 Teva Pharma Processes for preparing clarithromycin polymorphs and novel polymorph iv
AU2261901A (en) 2000-01-11 2001-07-24 Teva Pharma Processes for preparing clarithromycin polymorphs
HUP0302466A2 (hu) * 2000-02-29 2003-11-28 Teva Pharmaceutical Industries Ltd. Eljárások clarithromycin, clarithromycin intermedier, gyakorlatilag oximmentes clarithromycin és ezt tartalmazó gyógyszerkészítmény előállítására
HRP20020885B1 (en) 2002-11-11 2007-05-31 GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o. SUBSTITUTED 9a-N-{N'-[4-(SULFONYL)PHENYLCARBAMOYL]}DERIVATIVES 9-DEOXO-9-DIHYDRO-9a-AZA-9a-HOMOERITHROMYCIN A AND 5-O-DESOZAMINYL-9-DEOXO-9-DIHYDRO-9a-AZA-9a-HOMOERITHRONOLIDE A
HRP20020991A2 (en) 2002-12-12 2005-02-28 Pliva-Istra�iva�ki institut d.o.o. N"-Substituted 9a-N-(N'-carbamoyl-Gamma-aminopropyl), 9a-N-(N'? -thiocarbamoyl-Gamma-aminopropyl), 9a-N-(N'-((Beta-cyanoethyl)-N'-carbamoyl-Gamma? -aminopropyl) and 9a-N-(N'-(Beta-cyanoethyl)-N'-thiocarbamoyl-Gamma? -aminopropyl) derivatives of 9-de
AU2003271408B2 (en) * 2002-12-31 2008-07-17 Alembic Limited A process for the purification of roxithromycin
CN101541331A (zh) 2006-08-24 2009-09-23 沃克哈特研究中心 具有抗微生物活性的新颖大环内酯和酮内酯
US20090005326A1 (en) * 2007-06-26 2009-01-01 Idexx Laboratories, Inc. Single dose roxithromycin
CA2820451C (en) 2010-12-09 2017-12-12 Wockhardt Limited Ketolide compounds
WO2012117357A2 (en) 2011-03-01 2012-09-07 Wockhardt Limited Process for preparation of ketolide intermediates
WO2012127351A1 (en) 2011-03-22 2012-09-27 Wockhardt Limited Process for preparation of ketolide compounds
CN102219816A (zh) * 2011-05-12 2011-10-19 浙江国邦药业有限公司 一种罗红霉素的纯化方法
PL222631B1 (pl) 2012-11-14 2016-08-31 Gdański Univ Medyczny Kompozycja farmaceutyczna zawierająca roksytromycynę, sposób jej wytwarzania oraz zastosowanie medyczne tej kompozycji i produkt leczniczy zawierający kompozycję
CN104163840A (zh) * 2013-08-30 2014-11-26 郑州后羿制药有限公司 一种罗红霉素的精制方法
FR3049861A1 (fr) 2016-04-07 2017-10-13 Univ Claude Bernard Lyon Nouvelles compositions antivirales pour le traitement de la grippe

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU31319B (en) * 1967-08-03 1973-04-30 Pliva Pharm & Chem Works Postupak za dobijanje acil derivata eritromicin oksima
US3869444A (en) * 1972-10-10 1975-03-04 Abbott Lab Esters of erythromycin oxime
ES434842A1 (es) * 1975-02-19 1976-12-01 Andreu Sa Dr Procedimiento para la preparacion de esteres de la oxima deeritromicina.
DK139522C (da) * 1975-04-07 1979-08-20 Thomae Gmbh Dr K Analogifremgangsmaade til fremstilling af 9-iminoalkylamino-erythromyciner eller syreadditionssalte deraf
DE2515077A1 (de) * 1975-04-07 1976-10-28 Thomae Gmbh Dr K Neue 9-alkylidenamino-erythromycine, ihre salze und verfahren zu ihrer herstellung
DE2515076A1 (de) * 1975-04-07 1976-10-28 Thomae Gmbh Dr K Neue erythromycinderivate, deren salze und verfahren zu ihrer herstellung
DE2750288A1 (de) * 1977-11-10 1979-05-17 Thomae Gmbh Dr K Neue 9-(omega-heteroarylamino- alkylamino)-erythromycine, ihre salze, verfahren zu ihrer herstellung und diese enthaltende arzneimittel

Also Published As

Publication number Publication date
AU537247B2 (en) 1984-06-14
HK586A (en) 1986-01-10
IL61808A (en) 1986-12-31
FI810042L (fi) 1981-07-12
ZA808108B (en) 1982-01-27
JPS56100799A (en) 1981-08-12
DK157878B (da) 1990-02-26
EP0033255B1 (fr) 1984-08-29
IE810046L (en) 1981-07-11
IL61808A0 (en) 1981-01-30
FR2473525B1 (zh) 1983-04-15
NL930097I2 (nl) 1995-04-03
FR2473525A1 (fr) 1981-07-17
ES498395A0 (es) 1981-11-01
US4349545A (en) 1982-09-14
NL930097I1 (nl) 1993-10-01
FI69473C (fi) 1986-02-10
LU88283I2 (fr) 1994-09-09
PT72331B (fr) 1982-07-23
KR850000964B1 (ko) 1985-07-02
BG61369B2 (bg) 1997-06-30
FI69473B (fi) 1985-10-31
ES8200702A1 (es) 1981-11-01
CA1162535A (fr) 1984-02-21
OA06719A (fr) 1982-06-30
IE50680B1 (en) 1986-06-11
DK157878C (da) 1990-07-30
AU6613181A (en) 1981-07-16
GT198500080A (es) 1987-03-06
EP0033255A1 (fr) 1981-08-05
JPS6237639B2 (zh) 1987-08-13
HU187760B (en) 1986-02-28
MY8500984A (en) 1985-12-31
DK7881A (da) 1981-07-12
PT72331A (fr) 1981-02-01
KR830005258A (ko) 1983-08-03
GR73103B (zh) 1984-02-02
DE3165720D1 (en) 1984-10-04

Similar Documents

Publication Publication Date Title
DE3165720D1 (en) Oximes derived from erythromycin a, their preparation, their application in pharmaceuticals and pharmaceutical compositions containing them
IL66099A0 (en) N-aryl-piperazinealkanamides,their preparation and pharmaceutical compositions containing them
DE3263633D1 (en) Imidazodiazepines, process for their preparation and pharmaceutical compositions containing them
IL65257A0 (en) Arylcyclo-butanealkylamine derivatives,their preparation and pharmaceutical compositions containing them
IL67826A0 (en) Pyrazolooxazines,pyrazolothiazines and pyrazoloquinolines,their preparation and pharmaceutical compositions containing them
IL64777A0 (en) 3-aminopropoxyaryl derivatives,their preparation and pharmaceutical compositions containing them
IL66683A0 (en) Benzo-heterocycles,their preparation and pharmaceutical compositions containing them
IL66408A (en) 3-amino-pyridazine derivatives,their preparation and pharmaceutical compositions containing them
ZA818371B (en) Nortropanols,their preparation and pharmaceutical compositions containing these
IL67180A0 (en) Morphinate derivatives,their preparation and pharmaceutical compositions containing them
IL60678A0 (en) 3-amino-syndone-imines, their preparation and pharmaceutical compositions containing them
IL63368A0 (en) 4,5-diaryl-alpha-polyfluoroalkyl-1h-imidazole-2-methanamines,their preparation and pharmaceutical compositions containing them
IL68497A0 (en) Benzoazacycloalkyl-spiro-imidazolidines,their preparation and pharmaceutical compositions containing them
IL64498A0 (en) Phenylalkylamines,their preparation and pharmaceutical compositions containing them
IL60918A (en) 6-pyridazinones,their preparation and pharmaceutical compositions containing them
ZA816844B (en) Substituted iminodiacids,their preparation and pharmaceutical compositions containing them
IL66227A0 (en) Amidobenzamides and their salts,their preparation and pharmaceutical compositions containing them
ZA827055B (en) Substituted ethylamines,processes for their preparation,and pharmaceutical compositions thereof
IL65422A (en) 2-piperazino-pyrimidine derivatives,their preparation and pharmaceutical compositions containing them
IL64563A0 (en) 3,4-bis-substituted 1,2,5-oxidiazole 2-oxides,their preparation and pharmaceutical compositions containing them
IL64252A (en) 3,3-dimethyl-indolin-2-ones,their preparation and pharmaceutical compositions containing them
IL65177A0 (en) Fluoroprostacylins,their preparation and pharmaceutical compositions containing them
IL66385A0 (en) Benzotriazoles,their preparation and pharmaceutical compositions containing them
IL65653A0 (en) Aminocyclitol derivatives,their preparation and pharmaceutical compositions containing them
EP0018077A3 (en) Phenylmorphans, processes for their preparation, pharmaceutical compositions containing them, and 4-phenyl-tetrahydro-pyridines